Itraconazole Oral Solution 10 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Oral Solution

Available Strengths: 10 mg/mL

Reference Brands: Sporanox(US & EU)

Category: Anti-fungal

traconazole oral solution inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane formation. It effectively treats systemic and dermatophyte fungal infections. Benefits include excellent tissue penetration, broad-spectrum activity, oral administration, and a good safety profile—making it an essential choice for managing various fungal diseases.

Product Description:

Itraconazole oral solution is approved in the EU and US for treating fungal infections. In the EU, Janssen’s Sporanox oral solution is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA-approved Sporanox oral solution and generics are backed by comprehensive clinical data, biosimilarity assessments, and pharmacovigilance. Both regions require detailed regulatory dossiers for approval and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in regulatory solutions, ensuring efficient market access and adherence to regulatory standards for itraconazole oral solutions.